In vivo assessment of left ventricular hypertrophy in rats: necropsy validation

Vili Stoyanova, B. Dobreva, Evghenii Ghenev, Nikolai Zhelev

Research output: Contribution to journalArticle

Abstract

Development of left ventricular hypertrophy (LVH) is a compensatory response to hemodynamic overload and echocardiography is a noninvasive, sensitive method to study the process of myocardial remodeling and functional changes. In this study we assessed in vivo the time-course of the left ventricular structural and functional changes after aortic banding and validated them by necropsy. Wistar rats were subjected to abdominal aorta banding (AAB) or sham operation. A control group of age- and sex-matched, were maintained and sacrificed in parallel with operated animals. Echocardiographic assessment was performed before and at days 10, 15, 20, 25, 35 and 45 post-operation. Some rats were euthanized at each time point to obtain body and organ weights. Echo left ventricular wall thickness (LVWT) increased progressively on the 10th and the 15th day, then there was a reduction on the 20th day, followed by a second marked increase on the 25th day and after 35th day it presented a plateau. On the 45th day LVWT in AAB rats increased to 35% compared with SH. The percentage of left ventricular fractional shortening was similar in different groups at each time point. These parameters remained stable in control groups. Echocardiographic parameters and actual whole heart mass were well coincided. Echo LVWT correlated well with actual whole heart mass (r=0.724, P < 0.001). We developed an easier model of significant LVH in rats, not requiring thoracotomy. The progression of myocardial hypertrophy is a time-dependent, stage developing process. The model is suitable to study the mechanisms governing the development of left ventricular hypertrophy for therapeutic benefit.

Original languageEnglish
Pages (from-to)124-132
Number of pages9
JournalBiotechnology & Biotechnological Equipment
Volume20
Issue number2
DOIs
StatePublished - 2006

Fingerprint

Left Ventricular Hypertrophy
Abdominal Aorta
Organ Size
Thoracotomy
Hypertrophy
Echocardiography
Wistar Rats
Hemodynamics
Body Weight

Cite this

Stoyanova, Vili; Dobreva, B.; Ghenev, Evghenii; Zhelev, Nikolai / In vivo assessment of left ventricular hypertrophy in rats : necropsy validation.

In: Biotechnology & Biotechnological Equipment, Vol. 20, No. 2, 2006, p. 124-132.

Research output: Contribution to journalArticle

@article{e0d7ca9e435747c7ad010b4b8138eac1,
title = "In vivo assessment of left ventricular hypertrophy in rats: necropsy validation",
abstract = "Development of left ventricular hypertrophy (LVH) is a compensatory response to hemodynamic overload and echocardiography is a noninvasive, sensitive method to study the process of myocardial remodeling and functional changes. In this study we assessed in vivo the time-course of the left ventricular structural and functional changes after aortic banding and validated them by necropsy. Wistar rats were subjected to abdominal aorta banding (AAB) or sham operation. A control group of age- and sex-matched, were maintained and sacrificed in parallel with operated animals. Echocardiographic assessment was performed before and at days 10, 15, 20, 25, 35 and 45 post-operation. Some rats were euthanized at each time point to obtain body and organ weights. Echo left ventricular wall thickness (LVWT) increased progressively on the 10th and the 15th day, then there was a reduction on the 20th day, followed by a second marked increase on the 25th day and after 35th day it presented a plateau. On the 45th day LVWT in AAB rats increased to 35% compared with SH. The percentage of left ventricular fractional shortening was similar in different groups at each time point. These parameters remained stable in control groups. Echocardiographic parameters and actual whole heart mass were well coincided. Echo LVWT correlated well with actual whole heart mass (r=0.724, P < 0.001). We developed an easier model of significant LVH in rats, not requiring thoracotomy. The progression of myocardial hypertrophy is a time-dependent, stage developing process. The model is suitable to study the mechanisms governing the development of left ventricular hypertrophy for therapeutic benefit.",
author = "Vili Stoyanova and B. Dobreva and Evghenii Ghenev and Nikolai Zhelev",
year = "2006",
doi = "10.1080/13102818.2006.10817354",
volume = "20",
pages = "124--132",
journal = "Biotechnology & Biotechnological Equipment",
issn = "1310-2818",
number = "2",

}

In vivo assessment of left ventricular hypertrophy in rats : necropsy validation. / Stoyanova, Vili; Dobreva, B.; Ghenev, Evghenii; Zhelev, Nikolai.

In: Biotechnology & Biotechnological Equipment, Vol. 20, No. 2, 2006, p. 124-132.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In vivo assessment of left ventricular hypertrophy in rats

T2 - Biotechnology & Biotechnological Equipment

AU - Stoyanova,Vili

AU - Dobreva,B.

AU - Ghenev,Evghenii

AU - Zhelev,Nikolai

PY - 2006

Y1 - 2006

N2 - Development of left ventricular hypertrophy (LVH) is a compensatory response to hemodynamic overload and echocardiography is a noninvasive, sensitive method to study the process of myocardial remodeling and functional changes. In this study we assessed in vivo the time-course of the left ventricular structural and functional changes after aortic banding and validated them by necropsy. Wistar rats were subjected to abdominal aorta banding (AAB) or sham operation. A control group of age- and sex-matched, were maintained and sacrificed in parallel with operated animals. Echocardiographic assessment was performed before and at days 10, 15, 20, 25, 35 and 45 post-operation. Some rats were euthanized at each time point to obtain body and organ weights. Echo left ventricular wall thickness (LVWT) increased progressively on the 10th and the 15th day, then there was a reduction on the 20th day, followed by a second marked increase on the 25th day and after 35th day it presented a plateau. On the 45th day LVWT in AAB rats increased to 35% compared with SH. The percentage of left ventricular fractional shortening was similar in different groups at each time point. These parameters remained stable in control groups. Echocardiographic parameters and actual whole heart mass were well coincided. Echo LVWT correlated well with actual whole heart mass (r=0.724, P < 0.001). We developed an easier model of significant LVH in rats, not requiring thoracotomy. The progression of myocardial hypertrophy is a time-dependent, stage developing process. The model is suitable to study the mechanisms governing the development of left ventricular hypertrophy for therapeutic benefit.

AB - Development of left ventricular hypertrophy (LVH) is a compensatory response to hemodynamic overload and echocardiography is a noninvasive, sensitive method to study the process of myocardial remodeling and functional changes. In this study we assessed in vivo the time-course of the left ventricular structural and functional changes after aortic banding and validated them by necropsy. Wistar rats were subjected to abdominal aorta banding (AAB) or sham operation. A control group of age- and sex-matched, were maintained and sacrificed in parallel with operated animals. Echocardiographic assessment was performed before and at days 10, 15, 20, 25, 35 and 45 post-operation. Some rats were euthanized at each time point to obtain body and organ weights. Echo left ventricular wall thickness (LVWT) increased progressively on the 10th and the 15th day, then there was a reduction on the 20th day, followed by a second marked increase on the 25th day and after 35th day it presented a plateau. On the 45th day LVWT in AAB rats increased to 35% compared with SH. The percentage of left ventricular fractional shortening was similar in different groups at each time point. These parameters remained stable in control groups. Echocardiographic parameters and actual whole heart mass were well coincided. Echo LVWT correlated well with actual whole heart mass (r=0.724, P < 0.001). We developed an easier model of significant LVH in rats, not requiring thoracotomy. The progression of myocardial hypertrophy is a time-dependent, stage developing process. The model is suitable to study the mechanisms governing the development of left ventricular hypertrophy for therapeutic benefit.

U2 - 10.1080/13102818.2006.10817354

DO - 10.1080/13102818.2006.10817354

M3 - Article

VL - 20

SP - 124

EP - 132

JO - Biotechnology & Biotechnological Equipment

JF - Biotechnology & Biotechnological Equipment

SN - 1310-2818

IS - 2

ER -